Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

Two from UFS heading for Rio
2016-07-18

Description: Rynhardt_Rio Tags: Rynhardt_Rio

The 800 m athlete from the University of the
Free State, Rynhardt van Rensburg, will soon
take part in his first Olympic Games in
Rio de Janeiro, Brazil.
Photo: Varsity Sports / Wessel Oosthuizen

It is the cherry on top for any sportsman or sportswoman. This is what DB Prinsloo, Director of KovsieSport, has to say about two athletes from the University of the Free State (UFS) being included in the South African team for the Olympic Games.

He says the officials and coaches at KovsieSport are extremely proud of Rynhardt van Rensburg (800 m) and Wayde van Niekerk (400 m). Although they qualified earlier, their names were read out on 14 July 2016 as part of the team of 137 athletes that will participate in Rio de Janeiro, Brazil, from 5 to 21 August.

In the footsteps of other UFS stars

They follow in the footsteps of former Kovsies like Leslé-Ann George (women’s hockey), Kate Roberts (triathlon), Johan Cronjé (1 500 m), and Frantz Kruger (discus), who represented South Africa at previous Olympics. Apart from these two, four former Kovsies were also included in the team for Rio. They are the Sevens Springbok Philip Snyman, Sevens coach Neil Powell, Chris Dednam as badminton coach and Roberts as team manager of the triathletes. Dednam also competed as a player at the Olympics. Ans Botha, the UFS sprint coach, will also accompany Van Niekerk.

“It is a highlight for any sportsman or sportswoman to be part of the Olympic Games. It is, for example, the same as it is for others to participate in a World Cup,” says Prinsloo.

Description: Wayde2_Rio Tags: Wayde2_Rio

Wayde van Niekerk

Van Niekerk shows mettle on birthday

Prinsloo is very happy for Van Rensburg, since the 24-year-old athlete has been injured for a long time and had to regain his form. On 24 June 2016, he won a bronze medal at the African Championships in Durban in a time of 1:46.15.

Prinsloo feels that Van Niekerk and Caster Semenya (800 m) are great contenders for medals in Rio. Van Niekerk, who celebrated his 24th birthday on 15 July 2016, continued his good preparation for the Olympics by trouncing his rivals on his birthday at a Diamond League event in Monaco in a time of in 44.12.

 

“It is a highlight for any sportsman or
sportswoman to be part of the Olympic Games.”










We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept